Cargando…

Risk factors for positive sentinel lymph node, lymphatic or hematogenous dissemination over time in patients with cutaneous melanoma

The aim of the present study was to assess the influence of localization, age or sex and histopathological characteristics upon the chance of developing lymphatic or hematogenous metastatic spread over time, or a positive sentinel lymph node in cutaneous melanoma patients. Patients from the Departme...

Descripción completa

Detalles Bibliográficos
Autores principales: Berghe, Alexandra S., Cobzac, Gheorghe, Dindelegan, George, Șenilă, Simona C., Baican, Corina I., Solomon, Carolina M., Rogojan, Liliana, Leucuța, Daniel C., Drugan, Tudor C., Bolboacă, Sorana D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8145265/
https://www.ncbi.nlm.nih.gov/pubmed/34055049
http://dx.doi.org/10.3892/etm.2021.10162
_version_ 1783697134463221760
author Berghe, Alexandra S.
Cobzac, Gheorghe
Dindelegan, George
Șenilă, Simona C.
Baican, Corina I.
Solomon, Carolina M.
Rogojan, Liliana
Leucuța, Daniel C.
Drugan, Tudor C.
Bolboacă, Sorana D.
author_facet Berghe, Alexandra S.
Cobzac, Gheorghe
Dindelegan, George
Șenilă, Simona C.
Baican, Corina I.
Solomon, Carolina M.
Rogojan, Liliana
Leucuța, Daniel C.
Drugan, Tudor C.
Bolboacă, Sorana D.
author_sort Berghe, Alexandra S.
collection PubMed
description The aim of the present study was to assess the influence of localization, age or sex and histopathological characteristics upon the chance of developing lymphatic or hematogenous metastatic spread over time, or a positive sentinel lymph node in cutaneous melanoma patients. Patients from the Department of Dermatology, County Emergency Hospital Cluj-Napoca (Cluj-Napoca, Romania), presenting with cutaneous melanoma confirmed histopathologically and a SPECT/CT or lymphoscintigraphic examination to detect the sentinel lymph node, were included in the present study. Our results revealed that Breslow index >2 mm [odds ratio (OR)=4.22, 95% confidence interval (CI) (1.12; 15.93)], presence of ulceration [OR=6.01, 95% CI (1.87; 19.35)], and positive sentinel lymph node [for at least one sentinel lymph node OR=3.58, 95% CI (1.06; 12.04)] were risk factors for hematogenous metastases. All these, except for the Breslow index >2 mm, were demonstrated to be a risk factor for lymphatic spread metastases over time. Ulceration and male sex also represented risk factors for a positive sentinel lymph node, men having a higher risk of developing sentinel lymph nodes than women [adjusted OR=2.27, 95% CI (1.00; 5.13)]. In conclusion, the predictors that influence the occurrence of lymphatic or hematogenous metastases may differ, ulceration and positive sentinel lymph node being common for both types of metastatic spread, while Breslow index being a significant predictor only for hematogenous metastases. Male sex and the presence of ulceration were demonstrated to be significant risk factors for positive sentinel lymph nodes.
format Online
Article
Text
id pubmed-8145265
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher D.A. Spandidos
record_format MEDLINE/PubMed
spelling pubmed-81452652021-05-28 Risk factors for positive sentinel lymph node, lymphatic or hematogenous dissemination over time in patients with cutaneous melanoma Berghe, Alexandra S. Cobzac, Gheorghe Dindelegan, George Șenilă, Simona C. Baican, Corina I. Solomon, Carolina M. Rogojan, Liliana Leucuța, Daniel C. Drugan, Tudor C. Bolboacă, Sorana D. Exp Ther Med Articles The aim of the present study was to assess the influence of localization, age or sex and histopathological characteristics upon the chance of developing lymphatic or hematogenous metastatic spread over time, or a positive sentinel lymph node in cutaneous melanoma patients. Patients from the Department of Dermatology, County Emergency Hospital Cluj-Napoca (Cluj-Napoca, Romania), presenting with cutaneous melanoma confirmed histopathologically and a SPECT/CT or lymphoscintigraphic examination to detect the sentinel lymph node, were included in the present study. Our results revealed that Breslow index >2 mm [odds ratio (OR)=4.22, 95% confidence interval (CI) (1.12; 15.93)], presence of ulceration [OR=6.01, 95% CI (1.87; 19.35)], and positive sentinel lymph node [for at least one sentinel lymph node OR=3.58, 95% CI (1.06; 12.04)] were risk factors for hematogenous metastases. All these, except for the Breslow index >2 mm, were demonstrated to be a risk factor for lymphatic spread metastases over time. Ulceration and male sex also represented risk factors for a positive sentinel lymph node, men having a higher risk of developing sentinel lymph nodes than women [adjusted OR=2.27, 95% CI (1.00; 5.13)]. In conclusion, the predictors that influence the occurrence of lymphatic or hematogenous metastases may differ, ulceration and positive sentinel lymph node being common for both types of metastatic spread, while Breslow index being a significant predictor only for hematogenous metastases. Male sex and the presence of ulceration were demonstrated to be significant risk factors for positive sentinel lymph nodes. D.A. Spandidos 2021-07 2021-05-05 /pmc/articles/PMC8145265/ /pubmed/34055049 http://dx.doi.org/10.3892/etm.2021.10162 Text en Copyright: © Berghe et al. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
spellingShingle Articles
Berghe, Alexandra S.
Cobzac, Gheorghe
Dindelegan, George
Șenilă, Simona C.
Baican, Corina I.
Solomon, Carolina M.
Rogojan, Liliana
Leucuța, Daniel C.
Drugan, Tudor C.
Bolboacă, Sorana D.
Risk factors for positive sentinel lymph node, lymphatic or hematogenous dissemination over time in patients with cutaneous melanoma
title Risk factors for positive sentinel lymph node, lymphatic or hematogenous dissemination over time in patients with cutaneous melanoma
title_full Risk factors for positive sentinel lymph node, lymphatic or hematogenous dissemination over time in patients with cutaneous melanoma
title_fullStr Risk factors for positive sentinel lymph node, lymphatic or hematogenous dissemination over time in patients with cutaneous melanoma
title_full_unstemmed Risk factors for positive sentinel lymph node, lymphatic or hematogenous dissemination over time in patients with cutaneous melanoma
title_short Risk factors for positive sentinel lymph node, lymphatic or hematogenous dissemination over time in patients with cutaneous melanoma
title_sort risk factors for positive sentinel lymph node, lymphatic or hematogenous dissemination over time in patients with cutaneous melanoma
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8145265/
https://www.ncbi.nlm.nih.gov/pubmed/34055049
http://dx.doi.org/10.3892/etm.2021.10162
work_keys_str_mv AT berghealexandras riskfactorsforpositivesentinellymphnodelymphaticorhematogenousdisseminationovertimeinpatientswithcutaneousmelanoma
AT cobzacgheorghe riskfactorsforpositivesentinellymphnodelymphaticorhematogenousdisseminationovertimeinpatientswithcutaneousmelanoma
AT dindelegangeorge riskfactorsforpositivesentinellymphnodelymphaticorhematogenousdisseminationovertimeinpatientswithcutaneousmelanoma
AT senilasimonac riskfactorsforpositivesentinellymphnodelymphaticorhematogenousdisseminationovertimeinpatientswithcutaneousmelanoma
AT baicancorinai riskfactorsforpositivesentinellymphnodelymphaticorhematogenousdisseminationovertimeinpatientswithcutaneousmelanoma
AT solomoncarolinam riskfactorsforpositivesentinellymphnodelymphaticorhematogenousdisseminationovertimeinpatientswithcutaneousmelanoma
AT rogojanliliana riskfactorsforpositivesentinellymphnodelymphaticorhematogenousdisseminationovertimeinpatientswithcutaneousmelanoma
AT leucutadanielc riskfactorsforpositivesentinellymphnodelymphaticorhematogenousdisseminationovertimeinpatientswithcutaneousmelanoma
AT drugantudorc riskfactorsforpositivesentinellymphnodelymphaticorhematogenousdisseminationovertimeinpatientswithcutaneousmelanoma
AT bolboacasoranad riskfactorsforpositivesentinellymphnodelymphaticorhematogenousdisseminationovertimeinpatientswithcutaneousmelanoma